Positive Evidence Stacks Up For Takeda's Dengue Vaccine
Phase II Support For Durability, Dosing
New long-term clinical data with Takeda’s dengue vaccine contender show a durable response against all four serotypes and support the dosing regimen in an ongoing pivotal study.
